2028, FDA and Pharmaceutical Companies - Pharmacy Technician Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2028

FDA

Pharmaceutical Companies

Eliquis generic availability, cost, and dosage

The Checkup by Singlecare

AUGUST 29, 2023

Food and Drug Administration (FDA) in 2012 as a brand-name drug. Although a generic was approved in 2019, generic apixaban will not be available on the market until at least April 2028. The FDA approved two applications for generic versions of Eliquis by the companies Micro Labs Limited and Mylan Pharmaceuticals, Inc.

Dosage

Dosage Labelling Insurance FDA

M&A outlook for pharma in 2025

European Pharmaceutical Review

JANUARY 23, 2025

For instance, patent expiries are set to wipe out $300 billion in revenues by 2028. With growing emergence of AI into 2025, the first part of the year saw the US Food and Drug Administration (FDA) issue draft recommendations on AI, which are set to address the safety, effectiveness or quality of drugs or biological products.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies FDA

Eliquis generic availability, cost, and dosage

M&A outlook for pharma in 2025

Stay Connected